Patent classifications
A61N7/02
METHODS OF TREATING TUMORS WITH PRO DRUGS
Methods of treating tumors by administering compounds to a patient are provided. Compounds such as pro drugs, e.g., 5-aminolevulinic acid (5-ALA), may be administered to the patient orally, by injection, intravenously, or topically, which then accumulate preferentially as compounds such as protoporphyrin IX (PpIX) in tumor cells. After such accumulation, compounds such as PpIX are then activated in various aspects to treat tumors cells, thereby treating cancer. Cancers such as glioblastoma may be treated.
SYSTEMS AND METHODS FOR MONITORING ENERGY APPLICATION TO DENERVATE A PULMONARY ARTERY
A catheter system for ablation of tissue around a blood vessel, e.g., the pulmonary artery, to reduce neural activity of nerves surrounding the blood vessel. The catheter system includes an elongate shaft having a proximal portion coupled to a handle, and a distal portion. The distal portion includes a transducer and an expandable anchor, which may be actuated to transition between a collapsed delivery state and an expanded deployed state where the anchor centralizes the transducer within the blood vessel. The transducer may be actuated to emit energy to reduce neural activity of the nerves surrounding the blood vessel. Systems and method are further provided for confirming that neural activity of the nerves surround the blood vessel has been sufficiently reduced.
SYSTEMS AND METHODS FOR MONITORING ENERGY APPLICATION TO DENERVATE A PULMONARY ARTERY
A catheter system for ablation of tissue around a blood vessel, e.g., the pulmonary artery, to reduce neural activity of nerves surrounding the blood vessel. The catheter system includes an elongate shaft having a proximal portion coupled to a handle, and a distal portion. The distal portion includes a transducer and an expandable anchor, which may be actuated to transition between a collapsed delivery state and an expanded deployed state where the anchor centralizes the transducer within the blood vessel. The transducer may be actuated to emit energy to reduce neural activity of the nerves surrounding the blood vessel. Systems and method are further provided for confirming that neural activity of the nerves surround the blood vessel has been sufficiently reduced.
TREATING BLEEDING AND BLEEDING DISORDERS VIA HIGH INTENSITY FOCUSED ULTRASOUND STIMULATION OF THE SPLEEN
Apparatuses and methods for reducing or limiting bleeding in an animal by focused ultrasound (FUS) stimulation of the spleen. The apparatuses and methods may be used treat blood disorders such as hemophilia, or to reduce hemorrhage in surgery or due to traumatic injury. The methods may be non-invasively administered to the patient by transcutaneous application of ultrasound energy.
AUTOMATIC PLANNING METHOD AND DEVICE FOR TISSUE ABLATION
Disclosed are an automatic planning method and a device for tissue ablation. The method includes: obtaining a three dimensional (3D) model of a to-be-ablated tissue through a 3D reconstruction technique; marking a cylindrical ablation point on the 3D model through an ablation planning, an axial direction of the ablation point is the same as a radio frequency direction of thermal ablation; and displaying an ablated area on the 3D model, the reconstruction technique includes: obtaining slice images of the to-be-ablated tissue in a plurality of directions, the slice image in each direction includes a plurality of two dimensional (2D) images; depicting, by a primitive, the to-be-ablated tissue on the 2D images in one direction; and constructing the 3D model of the to-be-ablated tissue through the 3D reconstruction technique based on the original 2D images.
METHOD FOR CONTROLLING FOCUSED ULTRASOUND THERAPY DEVICE BASED ON ARM ARCHITECTURE
Disclosed is a method for controlling a focused ultrasound therapy device based on an Acorn RISC Machine, the focused ultrasound therapy device being connected to a workstation and an ARM embedded processor running a linux operating system, the ARM embedded processor storing a first control program, the workstation storing a second control program, the method including: the first control program controlling the focused ultrasound therapy device by executing a task and sending a task execution result to the second control program; the task includes an internal event and an operation instruction, the internal event includes a timer event of the first control program and an interrupt message of a linux kernel, the second control program receives the operation instruction through the workstation and sends the operation instruction to the first control program.
SYSTEMS AND METHODS FOR USE WITH MRI-GUIDED FOCUSED ULTRASOUND
Systems and methods for sonicating a body within an organ of a patient include supplying ultrasound energy to the body in order to produce a liquified material, which can then be aspirated from the body via a catheter. Image guidance is used during aspiration of the liquified material.
ULTRASOUND SYSTEM, APPARATUS, AND METHOD FOR TRANSCRANIAL TREATMENT
The present disclosure relates to transcranial ultrasound systems, devices, and methods which are used for treatment rather than for imaging or medical diagnosis. In accordance with one aspect, a system for applying ultrasound energy includes at least three ultrasound applicators configured to be secured against a head of a person and configured to apply ultrasound energy to the head of the person when activated, and a controller configured to control activation and deactivation of the at least three ultrasound applicators based on a predetermined treatment sequence.
ULTRASOUND SYSTEM, APPARATUS, AND METHOD FOR TRANSCRANIAL TREATMENT
The present disclosure relates to transcranial ultrasound systems, devices, and methods which are used for treatment rather than for imaging or medical diagnosis. In accordance with one aspect, a system for applying ultrasound energy includes at least three ultrasound applicators configured to be secured against a head of a person and configured to apply ultrasound energy to the head of the person when activated, and a controller configured to control activation and deactivation of the at least three ultrasound applicators based on a predetermined treatment sequence.
Synthesis and application of microbubble-forming compounds
The present disclosure is directed to fatty-acid glycerol ester derivative compounds containing a targeting bisphosphonate group. The disclosure further includes pharmaceutical or biomedical compositions comprising these compounds, and methods of using these compounds and compositions forming microbubbles. The microbubbles have affinity for metal-containing, especially calcium-containing, bodies and/or biological targets. In certain embodiments, these compositions are useful for providing targeted placement of microbubbles capable of cavitation on application of high frequency energy.